Note 3. Segment Information

12 Months Ended

Mar. 31, 2013

Segment Reporting [Abstract]

Segment Reporting Disclosure [Text Block]

Note 3. Segment Information

We design, develop, manufacture, and market products for endoscopy in two reportable segments, medical and industrial.

Management evaluates the revenue and profitability performance of each of our segments to make operating and strategic decisions. We have no intersegment revenue.

Fiscal Year Ended March 31,	Medical			Industrial			Adjustments*			Consolidated
2013
Net sales	$	11,630		$	3,657		$	-		$	15,287
Gross profit		3,102			1,240			-			4,342
Operating loss		(8,381	)		(96	)		-			(8,477	)
Depreciation and amortization		772			23			-			795
Assets		11,833			1,466			(1,922	)		11,377
Expenditures for fixed assets		95			-			-			95
2012
Net sales	$	13,735		$	2,951		$	-		$	16,686
Gross profit		4,064			1,021			-			5,085
Operating loss		(9,868	)		(247	)		-			(10,115	)
Depreciation and amortization		789			43			-			832
Assets		13,140			1,413			(1,954	)		12,599
Expenditures for fixed assets		209			-			-			209

	March 31,
*Adjustments	2013			2012
Intercompany eliminations	$	(1,236	)	$	(1,268	)
Investment in subsidiaries		(686	)		(686	)
Total adjustments	$	(1,922	)	$	(1,954	)

The following table presents the reconciliation of loss before provision for income taxes:

	Fiscal Year Ended March 31,
	2013			2012
Operating loss	$	(8,477	)	$	(10,115	)
Interest expense, net		(499	)		(480	)
Debt cost expense		(272	)		(372	)
Loss on extinguishment of debt		(1,244	)		-
Other, net		(53	)		(48	)
Loss before provision for income taxes	$	(10,545	)	$	(11,015	)

The following table presents net sales based on the geographic location of the external customer. No individual foreign country accounted for more than 10% of our worldwide net sales in fiscal years 2013 and 2012.

	Fiscal Year Ended March 31,
	2013				2012
United States	$	10,296	67	%	$	11,349	68	%
Europe		3,527	23	%		3,700	22	%
Canada		471	3	%		303	2	%
Middle East and Africa		468	3	%		371	2	%
Asia and Australia		345	2	%		885	5	%
Central and South America		180	2	%		78	1	%
Net sales	$	15,287	100	%	$	16,686	100	%